The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity

Biochemical and Biophysical Research Communications

Volumn 273, Issue 1, 2000, Pages 316-321

  Yokoyama, Yasuhiro ^a   Takahashi, Yuichiro ^a   Shinohara, Ariyoshi ^a   Wan, Xiaoyun ^a   Takahashi, Seiji ^a   Niwa, Kenji ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catalytic subunit of telomerase; Endometrial carcinoma; Hammerhead ribozyme; RT PCR; Transient transfection

Indexed keywords

MESSENGER RNA; RIBOZYME; TELOMERASE;

ARTICLE; CANCER CELL CULTURE; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBUNIT; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034709645     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2939     Document Type: Article

References (33)

1. de Lange T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA. 91:1994;2882-2885.
2. Harley C. B. Telomere loss: Mitotic clock or genetic time tomb? Mutat. Res. 256:1991;271-282.
3. Rhyu M. S. Telomeres, telomerase, and immortality. J. Natl. Cancer Inst. 87:1995;884-893.
4. Shore D. Telomerase and telomere-binding proteins: Controlling the endgame. Trends Biochem. Sci. 22:1997;233-235.
5. Feng J., Funk W. D., Wang S. S., Weinrich S. L., Avilion A. A., Chiu C. P., Adams R. R., Chang E., Allsopp R. C., Yu J., Le S., West M. D., Harley C. B., Andrews W. H., Greider C. W., Villeponteau B. The RNA component of human telomerase. Science. 269:1995;1236-1241.
6. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Program A. E., Bass M. B., Arruda I., Robinson M. O. A mammalian telomerase-associated protein. Science. 275:1997;973-977.
7. Ramakrishnan S., Eppenberger U., Mueller H., Shinkai Y., Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 58:1998;622-625.
8. Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D., Ziaugra L., Beijersbergen R. L., Davidoff M. J., Liu Q., Bacchetti S., Haber D. A., Weinberg A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
9. Lingner J., Hughes T. R., Shevchenko A., Mann M., Lundblad V., Cech T. R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276:1997;561-567.
10. Beattie T. L., Zhou W., Robinson M. O., Harrington L. Reconstitution of human telomerase activity in vitro. Curr. Biol. 8:1998;177-180.
11. Weinrich S. L., Pruzan R., Ma L., Ouellette M., Tesmer V. M., Holt S. E., Bodnar A. G., Lichtsteiner S., Kim N. W., Trager J. B., Taylor R. D., Carlos R., Andrews W. H., Wright W. E., Shay J. W., Harley C. B., Morin G. B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17:1997;498-502.
12. Yokoyama Y., Morishita S., Takahashi Y., Hashimoto M., Tamaya T. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme. Br. J. Cancer. 76:1997;977-982.
13. Kashani-Sabet M., Funato T., Tone T., Jiao L., Wang W., Yoshida E., Kashfinn B. I., Shitara T., Wu A. M., Moreno J. G., Traweek S. T., Ahlering T. E., Scanlon K. J. Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res. Dev. 2:1992;3-15.
14. Haseloff J., Gerlach W. L. Simple RNA enzymes with new and highly specific endonuclease activities. Nature. 344:1988;585-591.
15. Koizumi M., Iwai S., Ohtsuka E. Construction of a series of several self-cleaving RNA duplexes using synthetic 21-mers. FEBS Lett. 228:1988;228-230.
16. Horikawa I., Cable P. L., Afshari C., Barrett J. C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59:1999;826-830.
17. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., Inoue M. Cancer Res. 59:1999;551-557.
18. Gunning, Leavitt J., Muscat G., Ng S., Kedes L. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA. 84:1987;4831-4835.
19. Castanotto D., Rossi J. J., Deshler J. O. Biological and functional aspects of catalytic RNAs. Crit. Rev. Eukaryot. Gene Expr. 2:1992;331-357.
20. Herschlag D. Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: More isn't always better. Proc. Natl. Acad. Sci. USA. 88:1991;6921-6925.
21. Bennett C. F. Antisense oligonucleotides: Is the glass half full or half empty? Biochem. Pharmacol. 55:1998;9-19.
22. Delihas N., Rokita S. E., Zheng P. Natural antisense RNA/target RNA interactions: Possible models for antisense oligonucleotide drug design. Nat. Biotechnol. 15:1997;751-753.
23. Pley H. W., Flaherty K. M., McKay D. B. Three-dimensional structure of a hammerhead ribozyme [see comments]. Nature. 372:1994;68-74.
24. Scott W. G., Finch J. T., Klug A. The crystal structure of an all-RNA hammerhead ribozyme: A proposed mechanism for RNA catalytic cleavage. Cell. 81:1995;991-1002.
25. Xu D., Gruber A., Peterson C., Pisa P. Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia. 10:1996;1354-1357.
26. Aldous W. K., Marean A. J., DeHart M. J., Matej L. A., Moore K. H. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines. Cancer. 85:1999;1523-1529.
27. Sato N., Mizumoto K., Kusumoto M., Niiyama H., Maehara N., Ogawa T., Tanaka M. 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells. FEBS Lett. 441:1998;318-321.
28. Gilley D., Lee M. S., Blackburn E. H. Altering specific telomerase RNA template residues affects active site function. Genes Dev. 9:1995;2214-2226.
29. Prescott J., Blackburn E. H. Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. Genes Dev. 11:1997;528-540.
30. Yokoyama Y., Takahashi Y., Shinohara A., Lian Z., Wan X., Niwa K., Tamaya T. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 58:1998;5406-5410.
31. Glukhov A., Zimnik O., Gordeev S., Severin S. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides. Biochem. Biophys. Res. Commun. 248:1998;368-371.
32. Yamaguchi F., Morrison R. S., Takahashi H., Teramoto A. Anti-telomerase therapy suppressed glioma proliferation. Oncol. Rep. 6:1999;773-776.
33. Naka K., Yokozaki H., Yasui W., Tahara H., Tahara E. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines. Biochem. Biophys. Res. Commun. 255:1999;753-758.